Get startedLog in
    Picture of Dancann Pharma A/S logo

    DANCAN — Dancann Pharma A/S News Story

    0.000.00%
    se flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro CapValue Trap
    All News

    Brief: Dancann Pharma Signs LoI With Canadian Tetra Bio-Pharma

    Picture of Dancann Pharma A/S logoDancann Pharma A/S
    25/02/2021 12:03
    Feb 25 (Reuters) - Dancann Pharma A/S  DANCAN.TE :
    * DANCANN PHARMA A/S SIGNS A LETTER OF INTENT WITH CANADIAN
TETRA
BIO-PHARMA INC. FOR THE EXCLUSIVE DISTRIBUTION OF REDUVO™
ADVERSA[® ]AND QIXLEEF™ IN SCANDINAVIA AND GERMANY
    * SIGNING OF A LETTER OF INTENT WITH CANADIAN TETRA
BIO-PHARMA
INC. CONCERNING EXCLUSIVE DISTRIBUTION OF CANNABINOID-BASED
MEDICINES REDUVO™ ADVERSA(®) AND QIXLEEF™ IN DENMARK, NORWAY,
SWEDEN, FINLAND, AND GERMANY
    * ESTIMATES REACHING PEAK SALES OF DKK 340 - 410 MLN BY
2028,
DEPENDING ON FINAL OUTCOME AND SCOPE OF AGREEMENT

Source text for Eikon:  ID:nWkr636xtJ 
Further company coverage:  DANCAN.TE 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

    Recent news on Dancann Pharma A/S

    See all news